URG11 promotes gastric cancer growth and invasion by activation of β-catenin signalling pathway

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 3, 2010, Pages 621-635

  Du, Rui ^a   Xia, Lin ^a   Sun, Shiren ^a   Lian, Zhaorui ^b   Zou, Xue ^a   Gao, Juan ^c   Xie, Huahong ^a   Fan, Rui ^a   Song, Jiugang ^a   Li, Xiaohua ^a   Liu, Jie ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

catenin; Gastric cancer; Invasion; Proliferation; URG11

Indexed keywords

BETA CATENIN; TRANSACTIVATOR PROTEIN; URG11 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL ADHESION; CELL LINE; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ADULT; AGED; BETA CATENIN; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

CERCOPITHECINE HERPESVIRUS 1;

EID: 77953527405     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00622.x     Document Type: Article

References (46)

1. Lian Z, Liu J, Li L. Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia. 2003, 5:229-44.
2. O'Leary JM, Hamilton JM, Deane CM. Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand factor type C module) from collagen IIA. J Biol Chem. 2004, 279:53857-66.
3. Nishiu J, Tanaka T, Nakamura Y. Identification of a novel gene (ECM2) encoding a putative extracellular matrix protein expressed predominantly in adipose and female-specific tissues and its chromosomal localization to 9q22.3. Genomics. 1998, 52:378-81.
4. Drickamer K, Fadden AJ. Genomic analysis of C-type lectins. Biochem Soc Symp. 2002, 69:59-72.
5. Tomasetto C, Masson R, Linares JL. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology. 2000, 118:70-80.
6. Christian S, Ahorn H, Koehler A. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem. 2001, 276:7408-14.
7. Lian Z, Liu J, Li L. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology. 2006, 43:415-24.
8. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004, 303:1483-7.
9. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 1999, 14:59-88.
10. Rubinfeld B, Albert I, Porfiri E. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science. 1996, 272:1023-6.
11. Rubinfeld B, Robbins P, El-Gamil M. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 1997, 275:1790-2.
12. Morin P, Sparks AB, Korinek V. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 1997, 275:1787-90.
13. Behrens J, von Kries JP, Kühl M. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 1996, 382:638-42.
14. Lee JH, Park CH, Jung KC. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell. Biochem Biophys Res Commun. 2005, 335:771-6.
15. Nakatsuru S, Yanagisawa A, Ichii S. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signetring cell carcinoma. Hum Mol Genet. 1992, 1:559-63.
16. Ebert MP, Fei G, Kahmann S. Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin genes are present in intestinal-type gastric cancer. Carcinogenesis. 2002, 23:87-91.
17. Clements WM, Wang J, Sarnaik A. β-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002, 62:3503-6.
18. Tsukamoto T, Yamamoto M, Ogasawara N. β-catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas. Cancer Sci. 2003, 94:1046-51.
19. Lowy AM, Clements WM, Bishop J. Beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res. 2006, 66:4734-41.
20. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. 2000, 182-3. Hamilton SRAaltonen LA. eds, Lyon, France, IARC Press, pp.
21. Greene FL, Page DL, Fleming ID. AJCC cancer staging handbook. 2002, 6th ed, New York, Springer-Verlag
22. Zou X, Li X, Liu J. Preparation and characterization of a specific monoclonal antibody against a new gene product: URG11. Hybridoma. 2006, 25:378-81.
23. Liu N, Bi F, Pan Y. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res. 2004, 10:6239-47.
24. Jin H, Pan Y, Zhao L. p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia. 2007, 9:471-8.
25. Schreiber E, Matthias P, Muller MM. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989, 17:6419.
26. van Golen KL, Wu ZF, Qiao XT. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res. 2000, 60:5832-8.
27. Song J, Xie H, Lian Z. Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia. 2006, 8:995-1002.
28. Wang F, Reierstad S, Fishman DA. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and progelatinase activation. Cancer Lett. 2006, 236:292-301.
29. Pan Y, Zhao L, Liang J. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J. 2006, 20:1886-8.
30. Alexander N, Wong C, Pignatelli M. β-catenin-a linchpin in colorectal carcinogenesis. Am J Pathol. 2002, 160:389-401.
31. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997, 349:1498-504.
32. Sherr CJ. Cancer cell cycles. Science. 1996, 274:1672-7.
33. Shinozaki H, Ozawa S, Ando N. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res. 1996, 2:1155-61.
34. Gillett C, Fantl V, Smith R. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994, 54:1812-7.
35. Yamamoto H, Ochiya T, Takeshita F. Enhanced skin carcinogenesis in cyclinD1-conditional transgenic mice: cyclinD1 alters keratinocyte response to calcium-induced terminal differentiation. Cancer Res. 2002, 62:1641-7.
36. Shtutman M, Zhurinsky J, Simcha I. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999, 96:5522-7.
37. Sato H, Takino T, Okada Y. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994, 370:61-5.
38. Okada Y. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis. Verh Dtsch Ges Pathol. 2000, 84:33-42.
39. Nomura H, Sato H, Seiki M. Expression of membrane type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995, 55:3263-6.
40. Atkinson SJ, Crabbe T, Cowell S. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem. 1995, 270:30479-85.
41. Kajita M, Itoh Y, Chiba T. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol. 2001, 153:893-904.
42. Ohuchi E, Imai K, Fujii Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997, 272:2446-51.
43. Hotary K, Allen E, Punturieri A. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 2000, 149:1309-23.
44. Yonemura Y, Endo Y, Takino T. Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer. Clin Exp Metastasis. 2000, 18:321-7.
45. Ueda J, Kajita M, Suenaga N. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene. 2003, 22:8716-22.
46. Nonaka T, Nishibashi K, Itoh Y. Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo. Mol Cancer Ther. 2005, 4:1157-66.